[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR064241A1 - Metodos para el tratamiento de la depresion - Google Patents

Metodos para el tratamiento de la depresion

Info

Publication number
AR064241A1
AR064241A1 ARP070104810A ARP070104810A AR064241A1 AR 064241 A1 AR064241 A1 AR 064241A1 AR P070104810 A ARP070104810 A AR P070104810A AR P070104810 A ARP070104810 A AR P070104810A AR 064241 A1 AR064241 A1 AR 064241A1
Authority
AR
Argentina
Prior art keywords
alkyl
depression
treatment
unsubstituted
phenyl
Prior art date
Application number
ARP070104810A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Sk Holdings Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39167608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR064241(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv, Sk Holdings Co Ltd filed Critical Janssen Pharmaceutica Nv
Publication of AR064241A1 publication Critical patent/AR064241A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Reivindicacion 1: Un método para el tratamiento de la depresion, que comprende la administracion a un sujeto que lo necesita, de una cantidad terapéuticamente eficaz de un compuesto de la formula 1 o de la formula 2, o una de sus formas de éster o sales aceptables para uso farmacéutico, donde: R1, R2, R3 y R4 son, de manera independiente, hidrogeno o alquilo C1-4, donde: alquilo C1-4 está sustituido o no sustituido con fenilo, y donde: fenilo está sustituido o no sustituido con hasta cinco sustituyentes seleccionados de manera independiente de: halogeno, alquilo C1-4, alcoxi C1-4, nitro, ciano y amino; donde amino está opcionalmente mono- o disustituido con alquilo C1-4; y X1, X2, X3, X4 y X5 son, de manera independiente, hidrogeno, fluor, cloro, bromo o yodo.
ARP070104810A 2006-10-30 2007-10-30 Metodos para el tratamiento de la depresion AR064241A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86340806P 2006-10-30 2006-10-30

Publications (1)

Publication Number Publication Date
AR064241A1 true AR064241A1 (es) 2009-03-25

Family

ID=39167608

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070104810A AR064241A1 (es) 2006-10-30 2007-10-30 Metodos para el tratamiento de la depresion

Country Status (22)

Country Link
US (1) US20080317883A1 (es)
EP (1) EP2081648A2 (es)
JP (1) JP2010508355A (es)
KR (1) KR20090110889A (es)
CN (1) CN101568362A (es)
AR (1) AR064241A1 (es)
AU (1) AU2007313865A1 (es)
BR (1) BRPI0718324A2 (es)
CA (1) CA2667949A1 (es)
CL (1) CL2007003120A1 (es)
EA (1) EA200970436A1 (es)
EC (1) ECSP099308A (es)
IL (1) IL198484A0 (es)
MX (1) MX2009004770A (es)
NI (1) NI200900073A (es)
NO (1) NO20092018L (es)
PE (1) PE20080929A1 (es)
SV (1) SV2009003247A (es)
TW (1) TW200835477A (es)
UY (1) UY30675A1 (es)
WO (1) WO2008055022A2 (es)
ZA (1) ZA200903771B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN103282346B (zh) 2011-01-13 2014-11-19 比皮艾思药物研发有限公司 用于制备苯基氨基甲酸酯衍生物的方法
EP2797880B1 (en) 2011-12-27 2017-03-01 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating epilepsy
US11202800B1 (en) * 2013-02-26 2021-12-21 Jeanne Fleming Methods for treating emotional cognitive disconnect
CN105228604A (zh) 2013-03-12 2016-01-06 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
EP2970110A4 (en) 2013-03-12 2016-12-28 Bio-Pharm Solutions Co Ltd PHENYL CARBAMATE COMPOUND AND COMPOSITION FOR PREVENTING OR TREATING PSYCHIATRIC DISORDER COMPRISING SAME
CN116478225B (zh) * 2023-04-12 2024-06-11 南京工业大学 一种丝氨酸改性的虫草素磷酸酯药物分子的制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US20030027817A1 (en) * 1998-05-29 2003-02-06 Tollefson Gary Dennis Combination therapy for treatment of bipolar disorders
PT1401424E (pt) * 2001-02-27 2007-02-28 Ortho Mcneil Pharm Inc Compostos carbamato para utilização na prevenção ou tratamento de distúrbios psicóticos
ATE361745T1 (de) * 2001-02-27 2007-06-15 Ortho Mcneil Pharm Inc Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen
BR0207644A (pt) * 2001-02-27 2004-03-09 Ortho Mcneil Pharm Inc Compostos de carbamato para uso na prevenção ou no tratamento de distúrbio bipolar
EP1368021B1 (en) * 2001-02-27 2007-11-14 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating bipolar disorder
BRPI0518233A2 (pt) * 2004-10-28 2008-11-11 Sk Corp terapia adjunta para depressço

Also Published As

Publication number Publication date
KR20090110889A (ko) 2009-10-23
WO2008055022A3 (en) 2008-06-19
SV2009003247A (es) 2009-11-24
WO2008055022A2 (en) 2008-05-08
ZA200903771B (en) 2010-08-25
NO20092018L (no) 2009-05-26
AU2007313865A1 (en) 2008-05-08
EP2081648A2 (en) 2009-07-29
IL198484A0 (en) 2011-08-01
ECSP099308A (es) 2009-10-30
JP2010508355A (ja) 2010-03-18
CA2667949A1 (en) 2008-05-08
CN101568362A (zh) 2009-10-28
UY30675A1 (es) 2008-05-02
NI200900073A (es) 2010-02-25
BRPI0718324A2 (pt) 2013-11-26
MX2009004770A (es) 2009-08-17
EA200970436A1 (ru) 2009-12-30
PE20080929A1 (es) 2008-07-19
US20080317883A1 (en) 2008-12-25
TW200835477A (en) 2008-09-01
CL2007003120A1 (es) 2008-07-18

Similar Documents

Publication Publication Date Title
AR054551A1 (es) Metodos para la neuroproteccion
AR064241A1 (es) Metodos para el tratamiento de la depresion
AR054524A1 (es) Metodos y formas de dosificacion para reducir los efectos secundarios de compuestos de carbamato
CO5570670A2 (es) Pulmonar obstructiva cronica
CO6180427A2 (es) Tratamiento de los trastornos generalizados del desarrollo
PE20080552A1 (es) Derivados de alcoholes 1-fenil-2-piridinil alquilenicos como inhibidores de fosfodiesterasa
AR072331A2 (es) Derivados de acido mandelico, formulacion farmaceutica, procesos para la preparacion de estos derivados, y compuestos intermediarios
CL2012000999A1 (es) Compuestos derivados de pirazoloespirocetona sustituida, inhibidores de acetil-coa carboxilasa; composicion farmaceutica que los comprende; uso para tratar o retrasar la progresion o el inicio de diabetes tipo 2, higado graso no alcoholico (hgna) o la resistencia hepatica a la insulina.
AR052885A1 (es) Metodos para el control del intervalo qt
AR054550A1 (es) Metodos para tratar la epileptogenesis
AR065655A1 (es) Tiazolidinonas y oxazolidinona fenoxi sustituidas,composiciones farmaceuticas que las contienen,y usos de las mismas para tratar afecciones oseas,cancer,y diabetes,entre otras.
AR063449A1 (es) Proceso quimico para derivados de quinazolina, intermediarios
NO20071921L (no) Fremgangsmater for behandling av epileptogenese og epilepsi
AR050261A2 (es) Aminoacidos con afinidad por la proteina alfa-2-delta y composiciones farmaceuticas que los contienen y su uso para preparar un medicamento
AR078142A1 (es) Compuestos inhibidores heteroarilicos biciclicos de pde4, las composiciones farmaceuticas que los contienen y el uso de los mismos para la preparacion de medicamentos.
AR063294A1 (es) Composiciones de carbamatos de fenilalquilo
ECSP055745A (es) Derivados de 1-(4-bencil-piperazin-1-il)-3-fenil-propenona
BR0207644A (pt) Compostos de carbamato para uso na prevenção ou no tratamento de distúrbio bipolar
CO6180505A2 (es) Metodos para el tratamiento de transtornos cocleares y vestibulares
AR077884A1 (es) (4-(5-aminometil- fenil)-piperidin-1-il)-1h-indol-3-il)-metanonas disustituidas
CO6160292A2 (es) Metodos de tratamiento de transtornos de comportamiento perturbador 877
AR032876A1 (es) Compuestos de carbamato para utilizar en la prevencion o tratamiento de los trastornos psicoticos
NI200700094A (es) Métodos para la neuroprotección
AR057300A1 (es) Estirilsulfonamidas, su obtencion y uso como agentes farmaceuticos
AR077418A1 (es) COMPUESTOS PIPERIDíNICOS, SU PROCEDIMIENTO DE PREPARACIoN, LAS COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SU USO EN EL TRATAMIENTO DE LOS TRASTORNOS COGNITIVOS

Legal Events

Date Code Title Description
FB Suspension of granting procedure